Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Piramal Pharma Ltd.
NSE: PPLPHARMA
|
BSE: 543635
|
ISIN: INE0DK501011
|
Industry: Pharmaceuticals
|
Expensive Performer
166.9500
-0.78
(
-0.47
%)
NSE
Jan 13, 2026
11:52 AM
New 52W Low in past week
Volume:
1.2M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Piramal Pharma Ltd.
14 May 2024
166.95
-0.47%
Piramal Pharma | Q4FY24 Result Update
Buy:
Piramal Pharma Ltd.
by
Edelweiss
Target: 209
Target
Edelweiss
CDMO business to drive growth
Piramal Pharma Ltd. has an
average target
of 262.67 from 3 brokers.
More from Piramal Pharma Ltd.
Recommended
Market trades flat, KPI Green Energy signs Rs 4,000 crore renewable energy pact
Trendlyne Marketwatch |
13 Jan 2026, 11:27AM
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026, 06:40PM
Five Interesting Stocks Today - January 9, 2026
The Baseline |
09 Jan 2026